James T. Willerson

Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX.

Texas Heart Institute provides an avenue for exchange of ideas relating to the clinical and research activities. It provide an avenue for exchange of ideas relating to the clinical and research activities among the present and former Cardiology fellows, trainees, and teaching staff of the Texas Heart Institute. The company was founded by Denton A. Cooley in 1989 and is headquartered in Houston, TX.

Technology & Entrepreneurship Center of Houston operates as a non-profit organization created to accelerate the growth of Houston’s innovation ecosystem. It aligns ecosystem support around strategic initiatives that are connecting, attracting, and promoting startups, investors, corporations, government, and universities. The company was founded in October 2017 and is headquartered in Houston, TX.

St. Luke's Episcopal Hospital provides medical and healthcare services. Its services include home health care, outpatient, surgical, cancer care, pulmonary care, rehabilitation therapy, and other health care services. The company was founded in 1954 and is headquartered in Houston, TX

Memorial Hermann Health System operates as a non-profit organization that provides healthcare services. It specializes in back pain and spine care, cancer, children's health, digestive health, emergency services, heart and vascular care, neurosurgery, neurology, stroke, orthopedics, sports medicine, rehabilitation and physical therapy, sleep medicine, transplant center, weight loss, and women?s health and maternity. Its services include alcohol and drug rehabilitation, diabetes education, home care, hospice, and medical equipment. The organization was founded 1907 and is headquartered in Houston, TX.

LoneStar Heart, Inc. develops cardiac restorative therapies for patients with heart failure. The firm functions in collaboration with the Texas Heart Institute, the University of Texas Southwestern Medical Center and a global network of leading clinicians. Its flagship product is Algisyl-LVR, a medical device under clinical development intended to prevent or reverse the progression of advanced heart failure in patients who have an enlarged left ventricle. The company was founded in June 2010 by James T. Willerson, Eric N. Olson and Olav B. Bergheim and is headquartered in Laguna Hills, CA.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.